Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies: A prospective study of 143 patients.
Harrys A. Torres(The University of Texas MD Anderson Cancer Center), Bruno Granwehr(The University of Texas MD Anderson Cancer Center), Parag Mahale(National Cancer Institute), Issam Raad, Ahmed O. Kaseb(The University of Texas MD Anderson Cancer Center), Aung Naing(The University of Texas MD Anderson Cancer Center), Minas P. Economides(NYU Langone Health), Jeff Hosry(The University of Texas MD Anderson Cancer Center), Francesco Turturro(The University of Texas MD Anderson Cancer Center), Andreas Kyvernitakis(The University of Texas MD Anderson Cancer Center)
Cited by 4
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Guidelines for the Management of Intravascular Catheter-Related Infections
|Clinical Infectious Diseases|2001|1.5k
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
|JAMA Oncology|2019|472
Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience
|British Journal of Haematology|2014|364
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
|The Lancet Oncology|2014|263